Default: Frontiers in Oncology

ISSN:

Journal Home

Journal Guideline

Frontiers in Oncology Q2 Unclaimed

Frontiers Media S.A. Switzerland
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Frontiers in Oncology is a journal indexed in SJR in Oncology and Cancer Research with an H index of 121. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1710 €. The scope of the journal is focused on cancer research, lung cancer, mesothelioma, esophageal cancer, sarcoma. It has an SJR impact factor of 1,138 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1,138.

Frontiers in Oncology focuses its scope in these topics and keywords: cancer, cell, tumor, radiotherapy, advanced, carcinoma, therapeutic, radiation, treatment, targets, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

1710 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Frontiers in Oncology

1,138

SJR Impact factor

121

H Index

7570

Total Docs (Last Year)

10182

Total Docs (3 years)

399987

Total Refs

48854

Total Cites (3 years)

10026

Citable Docs (3 years)

4.42

Cites/Doc (2 years)

52.84

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, cell, tumor, radiotherapy, advanced, carcinoma, therapeutic, radiation, treatment, targets, lung, brain, trail, oral, clinical, therapy, global, squamous, prostate, prospective, prediction, potential, detection, pancreatic, ovarian, effect, head, cancer research, lung cancer, mesothelioma, esophageal cancer, sarcoma

FAQS